1. Pink Sheet

US Is Holding On To Its Supply Of AstraZeneca COVID-19 Vaccine

 
• By Brenda Sandburg

US is keeping a ‘small inventory’ of AstraZeneca’s vaccine so people in the US can receive it immediately following authorization, White House official says. President Biden seeks to boost vaccine manufacturing in India in parntership with India, Japan, and Australia.

Covid vaccine stockpile
US government does not want to share stockpile of AstraZeneca's COVID-19 vaccine • Source: Shutterstock

There apparently is a tussle between AstraZeneca PLC and the US government over the supply of AstraZeneca’s COVID-19 vaccine. While the company agreed to provide 300 million doses of the vaccine to the government, it is not expected to receive emergency use authorization from the US Food and Drug Administration until next month so its existing US stockpile is going unused.

The New York Times reported that AstraZeneca had asked the Biden Administration for permission to send some of these vaccine doses to the European Union, where the vaccine has been...

More from Vaccines

More from Pink Sheet

Japan Price Cuts For Epkinly and Lunsumio Following CEA

 
• By Lisa Takagi

Japan is cutting more drug reimbursement prices following cost effectiveness analysis and is applying the methodology to a new group of products including Wegovy and Leqembi.

US FDA’s ‘Good Reputation’ For Science May Mean Loper Bright Not ‘Cataclysmic,’ Attorney Says

 
• By Malcolm Spicer

Bridget Dooling, a law school professor who reviewed draft regulations from the FDA and other agencies as an OMB attorney, said prior federal court decisions suggest judges typically defer to agency decisions based in science.

US FDA’s Prasad: ‘We Will Always Embrace Surrogate Endpoints’

 
• By Sarah Karlin-Smith

The new CBER director, once best known in the pharma world for criticizing accelerated approval, committed to expediting cancer drugs with surrogate endpoints.